The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Classification and Characterization of Therapeutic Antibody Aggregates
Open accessAbstract
A host of diverse stress techniques was applied to a monoclonal antibody (IgG(2)) to yield protein particles with varying attributes and morphologies. Aggregated solutions were evaluated for percent aggregation, particle counts, size distribution, morphology, changes in secondary and tertiary structure, surface hydrophobicity, metal content, and reversibility. Chemical modifications were also identified in a separate report (Luo, Q., Joubert, M. K., Stevenson, R., Narhi, L. O., and Wypych, J. (2011) J. Biol. Chem. 286, 25134-25144). Aggregates were categorized into seven discrete classes, based on the traits described. Several additional molecules (from the IgG(1) and IgG(2) subtypes as well as intravenous IgG) were stressed and found to be defined with the same classification system. The mechanism of protein aggregation and the type of aggregate formed depends on the nature of the stress applied. Different IgG molecules appear to aggregate by a similar mechanism under the same applied stress. Aggregates created by harsh mechanical stress showed the largest number of subvisible particles, and the class generated by thermal stress displayed the largest number of visible particles. Most classes showed a disruption of the higher order structure, with the degree of disorder depending on the stress process. Particles in all classes (except thermal stress) were at least partially reversible upon dilution in pH 5 buffer. High copper content was detected in isolated metal-catalyzed aggregates, a stress previously shown to produce immunogenic aggregates. In conclusion, protein aggregates can be a very heterogeneous population, whose qualities are the result of the type of stress that was experienced.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nearest neighbor pattern classification
Cover, T., & Hart, P. (1967) · IEEE Transactions on Information Theory · doi:10.1109/tit.1967.1053964 · Cited by 16,936
Filipe, V., Hawe, A., & Jiskoot, W. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0073-2 · Cited by 1,885
Effects of protein aggregates: An immunologic perspective
Rosenberg, A. S. (2006) · The AAPS Journal · doi:10.1208/aapsj080359 · Cited by 1,355
Extrinsic Fluorescent Dyes as Tools for Protein Characterization
Hawe, A., Sutter, M., & Jiskoot, W. (2008) · Pharmaceutical Research · doi:10.1007/s11095-007-9516-9 · Cited by 1,199
Protein aggregation: Pathways, induction factors and analysis
Mahler, H.-C., Friess, W., Grauschopf, U., & Kiese, S. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21566 · Cited by 901
GADDUM, J. H. (1955) · Nature · doi:10.1038/1761186b0 · Cited by 900
Protein aggregation—Pathways and influencing factors
Wang, W., Nema, S., & Teagarden, D. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.02.025 · Cited by 806
Protein aggregation kinetics, mechanism, and curve-fitting: A review of the literature
Morris, A. M., Watzky, M. A., & Finke, R. G. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.10.016 · Cited by 680
Size-Dependent Immunogenicity: Therapeutic and Protective Properties of Nano-Vaccines against Tumors
Fifis, T., Gamvrellis, A., Crimeen-Irwin, B., Pietersz, G. A., Li, J., Mottram, P. L., McKenzie, I. F. C., & Plebanski, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3148 · Cited by 664
Carpenter, J. F., Randolph, T. W., Jiskoot, W., Crommelin, D. J. A., Russell Middaugh, C., Winter, G., Fan, Y.-X., Kirshner, S., Verthelyi, D., Kozlowski, S., et al. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21530 · Cited by 595
Structural and functional changes in ultrasonicated bovine serum albumin solutions
Gülseren, İ., Güzey, D., Bruce, B. D., & Weiss, J. (2007) · Ultrasonics Sonochemistry · doi:10.1016/j.ultsonch.2005.07.006 · Cited by 574
Immunogenicity of protein therapeutics
De Groot, A. S., & Scott, D. W. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.07.011 · Cited by 545
NEUTRALIZING ANTIVIRAL B CELL RESPONSES
Bachmann, M. F., & Zinkernagel, R. M. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.235 · Cited by 471
Shaken, Not Stirred: Mechanical Stress Testing of an IgG1 Antibody
Kiese, S., Papppenberger, A., Friess, W., & Mahler, H.-C. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21328 · Cited by 397
Pressure provides new insights into protein folding, dynamics and structure
Silva, J. L., Foguel, D., & Royer, C. A. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01949-1 · Cited by 393
Molecular determinants of immunogenicity: the immunon model of immune response.
Dintzis, H. M., Dintzis, R. Z., & Vogelstein, B. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.10.3671 · Cited by 383
Lindgren, M., Sörgjerd, K., & Hammarström, P. (2005) · Biophysical Journal · doi:10.1529/biophysj.104.049700 · Cited by 349
Singh, S. K., Afonina, N., Awwad, M., Bechtold-Peters, K., Blue, J. T., Chou, D., Cromwell, M., Krause, H.-J., Mahler, H.-C., Meyer, B. K., et al. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22097 · Cited by 334
Self-citationBraun, A., Kwee, L., Labow, M. A., & Alsenz, J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012193326789 · Cited by 298
Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro
Morefield, G. L., Sokolovska, A., Jiang, D., HogenEsch, H., Robinson, J. P., & Hem, S. L. (2005) · Vaccine · doi:10.1016/j.vaccine.2004.07.050 · Cited by 293
Structural properties of monoclonal antibody aggregates induced by freeze–thawing and thermal stress
Hawe, A., Kasper, J. C., Friess, W., & Jiskoot, W. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.06.001 · Cited by 255
Existence of Different Structural Intermediates on the Fibrillation Pathway of Human Serum Albumin
Juárez, J., Taboada, P., & Mosquera, V. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2008.12.3901 · Cited by 223
Immunogenicity of biopharmaceuticals
Kessler, M., Goldsmith, D., & Schellekens, H. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl476 · Cited by 209
Krishnan, S., Chi, E. Y., Wood, S. J., Kendrick, B. S., Li, C., Garzon-Rodriguez, W., Wypych, J., Randolph, T. W., Narhi, L. O., Biere, A. L., et al. (2003) · Biochemistry · doi:10.1021/bi026528t · Cited by 202
Self-citationChemical Modifications in Therapeutic Protein Aggregates Generated under Different Stress Conditions
Luo, Q., Joubert, M. K., Stevenson, R., Ketchem, R. R., Narhi, L. O., & Wypych, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.160440 · Cited by 199
Self-citationHermeling, S., Schellekens, H., Maas, C., Gebbink, M. F. B. G., Crommelin, D. J. A., & Jiskoot, W. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20599 · Cited by 185
Determinants of Autoantibody Induction by Conjugated Papillomavirus Virus-Like Particles
Chackerian, B., Lenz, P., Lowy, D. R., & Schiller, J. T. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.11.6120 · Cited by 181
Immunogenicity of aggregates of recombinant human growth hormone in mouse models
Fradkin, A. H., Carpenter, J. F., & Randolph, T. W. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21834 · Cited by 170
A Role for Protein Misfolding in Immunogenicity of Biopharmaceuticals
Maas, C., Hermeling, S., Bouma, B., Jiskoot, W., & Gebbink, M. F. B. G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605984200 · Cited by 163
A Critical Review of Analytical Methods for Subvisible and Visible Particles
Narhi, L. O., Jiang, Y., Cao, S., Benedek, K., & Shnek, D. (2009) · Current Pharmaceutical Biotechnology · doi:10.2174/138920109788488905 · Cited by 152
Self-citationHermeling, S., Caetano, L. A., Damen, M. J. A., Slijper, M., Schellekens, H., Crommelin, D. J. A., & Jiskoot, W. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-8177-9 · Cited by 144
Effect of Ions on Agitation- and Temperature-Induced Aggregation Reactions of Antibodies
Fesinmeyer, R. M., Hogan, S., Saluja, A., Brych, S. R., Kras, E., Narhi, L. O., Brems, D. N., & Gokarn, Y. R. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9792-z · Cited by 141
Self-citationHari, S. B., Lau, H., Razinkov, V. I., Chen, S., & Latypov, R. F. (2010) · Biochemistry · doi:10.1021/bi100841u · Cited by 139
Denis, J., Majeau, N., Acosta‐Ramírez, E., Savard, C., Bédard, M.-C., Simard, S., Lecours, K., Bolduc, M., Paré, C., Willems, B. E., et al. (2007) · Virology · doi:10.1016/j.virol.2007.01.011 · Cited by 138
Qualification of FTIR spectroscopic method for protein secondary structural analysis
Jiang, Y., Li, C., Nguyen, X. C., Muzammil, S., Towers, E., Gabrielson, J. P., & Narhi, L. O. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22686 · Cited by 130
Self-citationQuantitation of protein particles in parenteral solutions using micro-flow imaging
Huang, C.-T., Sharma, D., Oma, P., & Krishnamurthy, R. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21575 · Cited by 129
High hydrostatic pressure as a tool to study protein aggregation and amyloidosis
Randolph, T. W., Seefeldt, M. B., & Carpenter, J. F. (2002) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(01)00346-6 · Cited by 109
Reipert, B. M., van Helden, P. M., Schwarz, H., & Baumgartner, C. K. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06359.x · Cited by 108
Characterization of Oligomeric Species on the Aggregation Pathway of Human Lysozyme
Frare, E., Mossuto, M. F., de Laureto, P. P., Tolin, S., Menzer, L., Dumoulin, M., Dobson, C. M., & Fontana, A. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.01.049 · Cited by 105
Tungsten-induced protein aggregation: Solution behavior
Jiang, Y., Nashed-Samuel, Y., Li, C., Liu, W., Pollastrini, J., Mallard, D., Wen, Z., Fujimori, K., Pallitto, M. M., Donahue, L., et al. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21778 · Cited by 105
Self-citationInfluence of aggregation on immunogenicity of recombinant human Factor VIII in hemophilia A mice
Purohit, V. S., Middaugh, C. R., & Balasubramanian, S. V. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20529 · Cited by 92
Foguel, D., & Silva, J. L. (2004) · Biochemistry · doi:10.1021/bi048864a · Cited by 91
Detection of IgG Aggregation by a High Throughput Method Based on Extrinsic Fluorescence
He, F., Phan, D. H. T., Hogan, S., Bailey, R. W., Becker, G. W., Narhi, L. O., & Razinkov, V. I. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22036 · Cited by 72
Self-citationNeed for new vaccine formulations and potential of particulate antigen and DNA delivery systems
Friede, M., & Aguado, M. T. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.10.001 · Cited by 65
Where disease pathogenesis meets protein formulation: Renal deposition of immunoglobulin aggregates
Demeule, B., Gurny, R., & Arvinte, T. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.08.008 · Cited by 64
Chen, S., Lau, H., Brodsky, Y., Kleemann, G. R., & Latypov, R. F. (2010) · Protein Science · doi:10.1002/pro.396 · Cited by 60
Silva, J. L., Cordeiro, Y., & Foguel, D. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2005.11.012 · Cited by 48
Li, C., & Li, T. (2009) · Current Pharmaceutical Biotechnology · doi:10.2174/138920109788488950 · Cited by 35
Souillac, P. O. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20423 · Cited by 32
The effects of denaturants on protein conformation and behavior at air/solution interface
Chang, S.-H., Chen, L.-Y., & Chen, W. (2004) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2004.10.015 · Cited by 19
Cited by
Immunogenicity of therapeutic proteins: Influence of aggregation
Ratanji, K. D., Derrick, J. P., Dearman, R. J., & Kimber, I. (2014) · Journal of Immunotoxicology · doi:10.3109/1547691x.2013.821564 · Cited by 589
Immunogenicity of Therapeutic Protein Aggregates
Moussa, E. M., Panchal, J. P., Moorthy, B. S., Blum, J. S., Joubert, M. K., Narhi, L. O., & Topp, E. M. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2015.11.002 · Cited by 529
Self-citationT-cell dependent immunogenicity of protein therapeutics: Preclinical assessment and mitigation
Jawa, V., Cousens, L. P., Awwad, M., Wakshull, E., Kropshofer, H., & De Groot, A. S. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.09.006 · Cited by 270
Joubert, M. K., Hokom, M., Eakin, C., Zhou, L., Deshpande, M., Baker, M. P., Goletz, T. J., Kerwin, B. A., Chirmule, N., Narhi, L. O., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.330902 · Cited by 268
Self-citationImmunogenicity of protein aggregates—Concerns and realities
Wang, W., Singh, S. K., Li, N., Toler, M. R., King, K. R., & Nema, S. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.04.040 · Cited by 266
Metadata
- Authors
- Joubert, M. K., Luo, Q., Nashed-Samuel, Y., Wypych, J., & Narhi, L. O.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2011-07
- Volume
- 286
- Issue
- 28
- Pages
- 25118-25133
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2011684044
- Cited by
- 316
- References
- 51
- FWCI
- 7.52
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.